Immunome Revenue and Competitors
Estimated Revenue & Valuation
- Immunome's estimated annual revenue is currently $8.5M per year.
- Immunome's estimated revenue per employee is $60,461
- Immunome's total funding is $93.9M.
Employee Data
- Immunome has 141 Employees.
- Immunome grew their employee count by 93% last year.
Immunome's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Technical Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | SVP, Research | Reveal Email/Phone |
8 | SVP, Chemistry | Reveal Email/Phone |
9 | VP, Chemical Process and Analytical Development | Reveal Email/Phone |
10 | VP, FP&A | Reveal Email/Phone |
Immunome Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 7 | -12% | N/A | N/A |
#2 | $4M | 38 | 81% | N/A | N/A |
#3 | N/A | 76 | 27% | N/A | N/A |
#4 | $0.9M | 5 | 0% | N/A | N/A |
#5 | $1.1M | 8 | 33% | N/A | N/A |
#6 | $10.9M | 61 | 7% | N/A | N/A |
#7 | $0.7M | 9 | 29% | N/A | N/A |
#8 | $4M | 20 | -5% | N/A | N/A |
#9 | $1.7M | 11 | 22% | N/A | N/A |
#10 | $7.6M | 49 | 2% | N/A | N/A |
What Is Immunome?
Immunome is a start-up biopharmaceutical company with a patented native, human antibody platform which enables us to harness the natural curative power of the human immune system. We believe that the novel antibodies generated by the human immune system have unique properties that may provide significant clinical benefit compared to those made by artificial systems such as mice or bacteria. We are using this game-changing technology to develop novel therapies for infections which currently have no or inadequate treatment options.
keywords:N/A
$93.9M
Total Funding
141
Number of Employees
$8.5M
Revenue (est)
93%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immunome News
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern - Additional $4.3 million in funding brings total DOD funding to $17.6 million. - Antibody cocktail (IMM-BCP-01) is a combination of three antibodies that bind ...
Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell discovery engine platform to discover and develop first-in-class antibody therapeutics, today announced a $4.3 million increase awarded by the U.S. Department of Defense’s (DOD) Joint Program Executi ...
EXTON, Pa.--(BUSINESS WIRE)--Mar 23, 2021-- Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that it advanced its first oncology program into IND-enabling studi ...
Other Companies in Lionville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23M | 145 | 10% | N/A |
#2 | $15M | 160 | -3% | N/A |
#3 | $37.7M | 174 | 41% | N/A |
#4 | $27.6M | 177 | -1% | $15M |
#5 | $136.3M | 213 | -11% | N/A |